These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 39066961)
1. Analysis of factors affecting the accuracy of low-dose insulin dosage using syringes and vials: a cross-sectional study in a Japanese regional hospital. Kondo M; Saji R; Yamada Y; Hayashi M; Shirai T Diabetol Int; 2024 Jul; 15(3):544-549. PubMed ID: 39101185 [TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes and Experiences with Prefilled Syringes Versus Vials for Intravitreal Administration of Anti-VEGF Treatments: A Systematic Review. Uzzan J; Mapani A; Cox O; Bagijn M; Saffar I Ophthalmol Ther; 2024 Sep; 13(9):2445-2465. PubMed ID: 39066961 [TBL] [Abstract][Full Text] [Related]
7. Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals. Antoszyk AN; Baker C; Calzada J; Cummings H; So J; Quezada-Ruiz C; Haskova Z PDA J Pharm Sci Technol; 2018; 72(4):411-419. PubMed ID: 29853609 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents. Finkelstein M; Katz G; Zur D; Rubowitz A; Moisseiev E Ophthalmologica; 2022; 245(1):34-40. PubMed ID: 34348344 [TBL] [Abstract][Full Text] [Related]
9. Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures. Souied E; Nghiem-Buffet S; Leteneux C; Bayer S; Derveloy A; Sagkriotis A; Becker G; Cohen SY Eur J Ophthalmol; 2015; 25(6):529-34. PubMed ID: 26044375 [TBL] [Abstract][Full Text] [Related]
10. Prefilled syringes for intravitreal injection reduce preparation time. Subhi Y; Kjer B; Munch IC Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034182 [TBL] [Abstract][Full Text] [Related]
11. Prefilled syringes for intravitreal drug delivery. Sassalos TM; Paulus YM Clin Ophthalmol; 2019; 13():701-706. PubMed ID: 31114147 [TBL] [Abstract][Full Text] [Related]
12. Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept. Russell MW; Chalasani M; Rana N; Muste JC; Rachitskaya AV; Talcott KE; Singh RP; Sharma S J Vitreoretin Dis; 2023; 7(6):498-503. PubMed ID: 37974923 [No Abstract] [Full Text] [Related]
13. Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation. Klaas JE; Bui V; Maierhofer N; Schworm B; Maier M; Priglinger SG; Siedlecki J Front Med (Lausanne); 2023; 10():1295633. PubMed ID: 37954554 [TBL] [Abstract][Full Text] [Related]